Education
About Us
Working with TipRanks
Follow Us
ROE - ETF AI Analysis
Top Page
Astoria US Quality Kings ETF (ROE)
Rating:72Outperform
Price Target:
$38.00
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid returns so far this year, indicating strong overall momentum.
Technology Sector Leadership
With significant exposure to the technology sector, the fund benefits from the strong performance of this high-growth industry.
Reasonable Expense Ratio
The ETF’s expense ratio is competitive, allowing investors to keep more of their returns.
Negative Factors
High Geographic Concentration
The fund is heavily concentrated in U.S. companies, which limits diversification and exposes it to domestic market risks.
Sector Overweight in Technology
Over one-third of the portfolio is allocated to technology, making the fund vulnerable to downturns in this sector.
Mixed Performance Among Top Holdings
Some of the top holdings, such as Eli Lilly & Co, have shown weaker performance, which could weigh on overall returns.
ROE vs. SPDR S&P 500 ETF (SPY)
AUM162.93M
RegionNorth America
Expense Ratio0.49%
Beta0.96
IssuerAstoria
Inception DateAug 01, 2023
Dividend Yield1.02%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume44,988
30 Day Avg. Volume29,438
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
40.27Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering102
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ROE Summary
The Astoria US Quality Kings ETF (Ticker: ROE) is an investment fund that focuses on high-quality U.S. companies with strong financial health and growth potential. It includes businesses from various sectors like technology, healthcare, and financials, with well-known names such as Micron and Caterpillar among its top holdings. This ETF is designed for investors looking to diversify their portfolios with stable and growth-oriented companies, making it a good option for long-term wealth building. However, new investors should be aware that the fund’s performance can fluctuate with the overall U.S. market, especially since it has significant exposure to technology stocks.
How much will it cost me?The Astoria US Quality Kings ETF (Ticker: ROE) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it focuses on a niche strategy of selecting high-quality U.S. companies, which requires more active decision-making. It’s designed for investors seeking a balance of stability and growth.
What would affect this ETF?The Astoria US Quality Kings ETF, with significant exposure to technology and financial sectors, could benefit from continued innovation and strong corporate earnings in these areas, especially if economic conditions remain favorable for growth. However, rising interest rates or regulatory changes affecting key sectors like technology and healthcare could pose challenges, potentially impacting the performance of its top holdings such as Micron and Eli Lilly. Its focus on high-quality U.S. companies provides stability, but broader economic downturns or geopolitical tensions could negatively affect its overall returns.
ROE Top 10 Holdings
The Astoria US Quality Kings ETF leans heavily on the technology sector, with names like Alphabet and Cisco Systems contributing steady gains, thanks to their strategic focus on AI and cloud services. Micron and Western Digital are rising stars, benefiting from strong momentum in AI-driven markets, though valuation concerns linger. Meanwhile, Cardinal Health and Eli Lilly are steady performers in healthcare, offering stability to the portfolio. With its U.S.-centric focus and a tilt toward tech and healthcare, the fund is well-positioned for growth, though its reliance on high-valuation names could pose risks.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 1.43% | $2.34M | $1.00T | 41.67% | 76 Outperform | |
| Cardinal Health | 1.37% | $2.23M | $49.77B | 71.93% | 65 Neutral | |
| Micron | 1.26% | $2.05M | $232.77B | 102.04% | 75 Outperform | |
| Alphabet Class A | 1.24% | $2.02M | $3.62T | 81.88% | 80 Outperform | |
| Western Digital | 1.22% | $2.00M | $47.59B | 109.53% | 79 Outperform | |
| Cencora | 1.20% | $1.96M | $70.90B | 49.24% | 76 Outperform | |
| Caterpillar | 1.19% | $1.95M | $257.59B | 38.48% | 76 Outperform | |
| Anglogold Ashanti PLC | 1.18% | $1.92M | $40.28B | 207.55% | 69 Neutral | |
| First Solar | 1.15% | $1.87M | $26.82B | 34.32% | 78 Outperform | |
| Cisco Systems | 1.15% | $1.87M | $300.68B | 29.97% | 77 Outperform |
ROE Technical Analysis
Neutral
―
Price Trends
34.41
Negative
33.56
Positive
31.77
Positive
Market Momentum
-0.22
Positive
41.31
Neutral
14.96
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ROE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 34.49, equal to the 50-day MA of 34.41, and equal to the 200-day MA of 31.77, indicating a neutral trend. The MACD of -0.22 indicates Positive momentum. The RSI at 41.31 is Neutral, neither overbought nor oversold. The STOCH value of 14.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ROE.
ROE Peer Comparison
Comparison Results
Performance Comparison
ROE
Astoria US Quality Kings ETF
33.62
1.96
6.19%
SYLD
Cambria Shareholder Yield ETF
―
―
―
PLDR
Putnam Sustainable Leaders ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
EBI
Longview Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents